Skip to main content
Premium Trial:

Request an Annual Quote

Robert Robb, Barbara Caulfield, Michael Malecek, Peter Root, Stephen Holmes, Jonathan Tolsedt

Premium
The University of Texas at Dallas has appointed Robert Robb as associate vice president for technology commercialization. He will oversee all activities of the school’s newly created Office of Technology Commercialization.
 
The new office will collaborate closely with the Institute for Innovation and Entrepreneurship in the UT-Dallas School of Management, where Robb is the director of venture development and a senior lecturer in entrepreneurship.
 
Robb previously served as director of the Office of Technology Management at the University of Michigan and executive director of venture development for Baylor College of Medicine.
 

 
Dewey & LeBoeuf said this week that Barbara Caulfield, Michael Malecek, and Peter Root are joining the firm as partners, and that Stephen Holmes is joining as counsel in the firm’s Silicon Valley office.
 
The team comes to Dewey & LeBoeuf from Affymetrix. They will focus on intellectual property and technology litigation with an emphasis on life sciences, and will provide corporate advice on IP strategy.
 
Over the past five years at Affymetrix, the team represented the company in several patent infringement cases in the Us District Courts in Delaware, California, and New York.
 
Prior to joining the firm, Caulfield served as executive vice president and general counsel at Affymetrix. She also served as United States District Judgefor the Northern District of California from 1991 to 1994. She will serve as co-chair of Dewey & LeBoeuf's intellectual property litigation group and managing partner of the Silicon Valley office.
 
Malecek most recently held the position of chief advocacy counsel at Affymetrix. He also served as assistant US attorney in the Eastern and Northern Districts of California, in the Computer Hacking and Intellectual Property Section. Prior to this, Malecek was a litigator at Latham & Watkins.
 
Root served as associate general counsel at Affymetrix, and has also served as the company's chief compliance officer. Prior to this, he was a partner in the litigation department at Orrick, Herrington & Sutcliffe, where he focused on securities litigation and complex business and commercial litigation.
 
Holmes served as assistant general counsel and was a member of the in-house litigation team at Affymetrix. Prior to that, Holmes litigated cases involving patents, trade secrets, trademarks, copyrights and antitrust issues, both in the US and UK, where he is also admitted to practice law.
 

 
Jonathan Tolsedt has been named licensing associate and patent agent in the technology transfer office at North Dakota State University and the NDSU Research Foundation.
 
Tolsedt previously worked for Rockwell Collins’ Commercial Avionics Division and at Phoenix International as a business development specialist. He has been a lecturer at NDSU, and also previously served as president and founder of Brainstorm Consulting.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.